| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/28/2005 | EP1442033B1 Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 09/28/2005 | EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 09/28/2005 | EP1051655B1 Methods and apparatus for accelerated orthokeratology |
| 09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 09/28/2005 | CN1675344A Oil or fat composition |
| 09/28/2005 | CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
| 09/28/2005 | CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 09/28/2005 | CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675173A Muscarinic agonists |
| 09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674931A T cell receptor CDR3 sequences and methods for detection |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674920A Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 09/28/2005 | CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 09/28/2005 | CN1674913A Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 09/28/2005 | CN1674910A Combination of azelastine and steroids |
| 09/28/2005 | CN1674909A Use of carboxamides for the treatment of tinnitus |
| 09/28/2005 | CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| 09/28/2005 | CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220501C Eye drop of double rhizoma coptidis used in treatment of ophthalmic viral infection |
| 09/28/2005 | CN1220491C Non-oral androgenic steroids used in preparation of medicine for improvement of raising sex hormones combined globulin level |
| 09/27/2005 | US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 09/27/2005 | US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis |
| 09/27/2005 | US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949555 Use of organic compounds |
| 09/27/2005 | US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 09/27/2005 | US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one |
| 09/27/2005 | US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/27/2005 | US6949218 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 09/22/2005 | WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |
| 09/22/2005 | WO2005087182A1 Functional powders |
| 09/22/2005 | WO2004060265A3 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 09/22/2005 | WO2003099270A8 Methods of treating allergic reactions |
| 09/22/2005 | US20050209325 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 09/22/2005 | US20050209272 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/22/2005 | US20050209261 Rho-kinase inhibitors |
| 09/22/2005 | US20050209252 Using an indazole compound |
| 09/22/2005 | US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/22/2005 | US20050209237 1-(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine or salt for treating diabetic macular edema |
| 09/22/2005 | US20050209230 2,4-Pyrimidinediamine compounds and their uses |
| 09/22/2005 | US20050209225 Substituted indoles and their use as integrin antagonists |
| 09/22/2005 | US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/22/2005 | US20050209206 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 09/22/2005 | US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/22/2005 | US20050209128 Statins, especially (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid, as nerve conduction velocity or nerve blood flow enhancers in combination with an aldose reductase inhibitor, an ACE inhibitor or an Angiotensin II antagonist |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture |
| 09/22/2005 | US20050208103 Contacting sclera with a therapeutic or diagnostic agent so as to permit its passage into the choroidal and retinal tissues; no significant systemic absorption or tissue damage; eye disorders |
| 09/22/2005 | US20050208061 Treatment of autoimmune diseases by oral administration of autoantigens |
| 09/22/2005 | US20050207989 High storage stability inhalable compositions |
| 09/22/2005 | CA2601278A1 Prevention of retinopathy by inhibition of the visual cycle |
| 09/21/2005 | EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use |
| 09/21/2005 | EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates |
| 09/21/2005 | EP1576964A1 Protease inhibitor |
| 09/21/2005 | EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 09/21/2005 | EP1575597A1 Use of rimexolone in the treatment of dry eye |
| 09/21/2005 | EP1575577A2 Composition for the prevention and treatment of inflammation of the ear |
| 09/21/2005 | EP1575558A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 09/21/2005 | EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 09/21/2005 | EP1575524A2 Proliferated cell lines and uses thereof |
| 09/21/2005 | EP1575516A2 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis |
| 09/21/2005 | EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 09/21/2005 | EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 09/21/2005 | EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists |
| 09/21/2005 | EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 09/21/2005 | EP1096934B1 Oxazolidinones to treat eye infections |
| 09/21/2005 | EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/21/2005 | CN1671856A Novel physiologically active substances |
| 09/21/2005 | CN1671744A Low molecular weight oversulfated polysaccharide |
| 09/21/2005 | CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/21/2005 | CN1671713A Novel derivative of flavone c-glycoside and composition containing the same |
| 09/21/2005 | CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 09/21/2005 | CN1671700A Substituted alkylamine derivatives and methods of use |
| 09/21/2005 | CN1671696A 激酶抑制剂 Kinase inhibitors |
| 09/21/2005 | CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors |
| 09/21/2005 | CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 09/21/2005 | CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 09/21/2005 | CN1671639A Novel biphenyl and biphenyl-like cannabinoids |
| 09/21/2005 | CN1671411A Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 09/21/2005 | CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases |
| 09/21/2005 | CN1671387A Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 09/21/2005 | CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 09/21/2005 | CN1669561A Medicine for treating ear diseases and preparation method thereof |
| 09/21/2005 | CN1219763C Substituted indole mannich bases |
| 09/21/2005 | CN1219513C Application of amyl ethyl quin ether hydrochloride |
| 09/21/2005 | CN1219508C Mucilage antiseptic medicine composition capable of being locally administrated and sustainably released and its preparing method |
| 09/20/2005 | US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 09/20/2005 | US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/20/2005 | US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |